Works about ELEPHANTIASIS

Results: 339
    1

    Evaluating the effectiveness of mass drug administration on lymphatic filariasis transmission and assessment of post-mass drug administration surveillance in Nigeria's Federal Capital Territory.

    Published in:
    Infectious Diseases of Poverty, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40249-025-01333-5
    By:
    • Amanyi-Enegela, Juliana Ajuma;
    • Kumbur, Joseph;
    • Okunade, Faizah;
    • Ashikeni, Donald;
    • Ishaya, Rinpan;
    • Sankar, Girija;
    • Adamani, William Enan;
    • Aderogba, Moses;
    • Makau-Barasa, Louise;
    • Emmanuel, Achai;
    • Ogundipe, Bosede Eunice;
    • Okoye, Chinwe;
    • Qureshi, Babar
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8

    Foreword—Genital Oedema.

    Published in:
    Journal of Wound Care, 2021, v. 30, n. Sup12a, p. 4, doi. 10.12968/jowc.2021.30.Sup12a.4
    By:
    • Quéré, Isabelle
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Lupus vulgaris.

    Published in:
    British Journal of Dermatology, 1984, v. 111, n. 4, p. 485
    By:
    • Lahey-De Boer, A.M.;
    • De La Faille, H.Baart;
    • Klokke, H.A.
    Publication type:
    Article
    32
    33
    34
    35

    Abdominal Elephantiasis: A Case Report.

    Published in:
    Journal of Cutaneous Medicine & Surgery, 2004, v. 8, n. 4, p. 229, doi. 10.1007/s10227-003-0104-2
    By:
    • Hanna, Dominique;
    • Cloutier, Richard;
    • Lapointe, Roch;
    • Desgagné, Antoine
    Publication type:
    Article
    36
    37
    38
    39
    40

    Repurposing Auranofin as a Lead Candidate for Treatment of Lymphatic Filariasis and Onchocerciasis.

    Published in:
    PLoS Neglected Tropical Diseases, 2015, v. 9, n. 2, p. 1, doi. 10.1371/journal.pntd.0003534
    By:
    • Bulman, Christina A.;
    • Bidlow, Chelsea M.;
    • Lustigman, Sara;
    • Cho-Ngwa, Fidelis;
    • Williams, David;
    • Rascón Jr, Alberto A.;
    • Tricoche, Nancy;
    • Samje, Moses;
    • Bell, Aaron;
    • Suzuki, Brian;
    • Lim, K. C.;
    • Supakorndej, Nonglak;
    • Supakorndej, Prasit;
    • Wolfe, Alan R.;
    • Knudsen, Giselle M.;
    • Chen, Steven;
    • Wilson, Chris;
    • Ang, Kean-Hooi;
    • Arkin, Michelle;
    • Gut, Jiri
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Reducing the Antigen Prevalence Target Threshold for Stopping and Restarting Mass Drug Administration for Lymphatic Filariasis Elimination: A Model-Based Cost-effectiveness Simulation in Tanzania, India and Haiti.

    Published in:
    Clinical Infectious Diseases, 2024, v. 78, p. S160, doi. 10.1093/cid/ciae108
    By:
    • Oliver, Mary Chriselda Antony;
    • Graham, Matthew;
    • Gass, Katherine M;
    • Medley, Graham F;
    • Clark, Jessica;
    • Davis, Emma L;
    • Reimer, Lisa J;
    • King, Jonathan D;
    • Pouwels, Koen B;
    • Hollingsworth, T Déirdre
    Publication type:
    Article
    50

    Subnational Projections of Lymphatic Filariasis Elimination Targets in Ethiopia to Support National Level Policy.

    Published in:
    Clinical Infectious Diseases, 2024, v. 78, p. S117, doi. 10.1093/cid/ciae072
    By:
    • Prada, Joaquin M;
    • Touloupou, Panayiota;
    • Kebede, Biruck;
    • Giorgi, Emanuelle;
    • Sime, Heven;
    • Smith, Morgan;
    • Kontoroupis, Periklis;
    • Brown, Paul;
    • Cano, Jorge;
    • Farkas, Hajnal;
    • Irvine, Mike;
    • Reimer, Lisa;
    • Rivera, Rocio Caja;
    • Vlas, Sake J de;
    • Michael, Edwin;
    • Stolk, Wilma A;
    • Pulan, Rachel;
    • Spencer, Simon E F;
    • Hollingsworth, T Déirdre;
    • Seife, Fikre
    Publication type:
    Article